Digitala Vetenskapliga Arkivet

Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
From neuroscience to evidence based psychological treatments - The promise and the challenge, ECNP March 2016, Nice, France
Univ Oxford, Univ Dept Psychiat, Oxford OX3 7JX, England.;Warneford Hosp, Oxford Hlth NHS Trust, Oxford OX3 7JX, England..
Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden..ORCID-id: 0000-0001-7319-3112
Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden..
Univ Oxford, Univ Dept Psychiat, Oxford OX3 7JX, England.;Warneford Hosp, Oxford Hlth NHS Trust, Oxford OX3 7JX, England..
Visa övriga samt affilieringar
2018 (Engelska)Ingår i: European Neuropsychopharmacology, ISSN 0924-977X, E-ISSN 1873-7862, Vol. 28, nr 2, s. 317-333Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

This ECNP meeting was designed to build bridges between different constituencies of mental illness treatment researchers from a range of backgrounds with a specific focus on enhancing the development of novel, evidence based, psychological treatments. In particular we wished to explore the potential for basic neuroscience to support the development of more effective psychological treatments, just as this approach is starting to illuminate the actions of drugs. To fulfil this aim, a selection of clinical psychologists, psychiatrists and neuroscientists were invited to sit at the same table. The starting point of the meeting was the proposition that we know certain psychological treatments work, but we have only an approximate understanding of why they work. The first task in developing a coherent mental health science would therefore be to uncover the mechanisms (at all levels of analysis) of effective psychological treatments. Delineating these mechanisms, a task that will require input from both the clinic and the laboratory, will provide a key foundation for the rational optimisation of psychological treatments. As reviewed in this paper, the speakers at the meeting reviewed recent advances in the understanding of clinical and cognitive psychology, neuroscience, experimental psychopathology, and treatment delivery technology focussed primarily on anxiety disorders and depression. We started by asking three rhetorical questions: What has psychology done for treatment? What has technology done for psychology? What has neuroscience done for psychology? We then addressed how research in five broad research areas could inform the future development of better treatments: Attention, Conditioning, Compulsions and addiction, Emotional Memory, and Reward and emotional bias. Research in all these areas (and more) can be harnessed to neuroscience since psychological therapies are a learning process with a biological basis in the brain. Because current treatment approaches are not fully satisfactory, there is an imperative to understand why not. And when psychological therapies do work we need to understand why this is the case, and how we can improve them. We may be able to improve accessibility to treatment without understanding mechanisms. But for treatment innovation and improvement, mechanistic insights may actually help. Applying neuroscience in this way will become an additional mission for ECNP.

Ort, förlag, år, upplaga, sidor
ELSEVIER SCIENCE BV , 2018. Vol. 28, nr 2, s. 317-333
Nyckelord [en]
Neuroscience, Cognitive Behaviour Therapy (CBT), Anxiety, Fear conditioning, Research Domain Criteria (RDoC)
Nationell ämneskategori
Neurovetenskaper
Identifikatorer
URN: urn:nbn:se:uu:diva-349835DOI: 10.1016/j.euroneuro.2017.10.036ISI: 000424840100009PubMedID: 29371024OAI: oai:DiVA.org:uu-349835DiVA, id: diva2:1204136
Forskningsfinansiär
Karolinska Institutets ForskningsstiftelseEU, Horisont 2020, 705641Tillgänglig från: 2018-05-07 Skapad: 2018-05-07 Senast uppdaterad: 2022-10-28Bibliografiskt granskad

Open Access i DiVA

fulltext(647 kB)605 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 647 kBChecksumma SHA-512
9fcd4c225991abfbbe38d1549b950e3014d2baf6aa6727ea01b1ea98f21304344b1e40828e74e9be6271bdd90e821c09caf61ae52fc15279ea8bf9c4a6dc653f
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Holmes, Emily A.Månsson, Kristoffer N.T.
Av organisationen
Institutionen för psykologi
I samma tidskrift
European Neuropsychopharmacology
Neurovetenskaper

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 605 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 229 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf